Diabetes and Endocrinology Topic Homepage

Type 2 Diabetes

,

This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:

Type 2 Diabetes Mellitus Knowledge Centre Provides prevalence statistics, treatment options, current diagnostic criteria from WHO and ADA and a section containing the latest guidelines.

Therapy Focus Compiles material on emerging insulin/incretin treatment combinations arranged across five informative sections.

‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ CME EACCME-accredited CME activity consisting of three modules and worth 1 European CME credit (ECMEC).

Type 1 Childhood Diabetes CME

,Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC) and should be able to:

  • Describe the psychosocial factors that can affect metabolic control
  • Discuss the rationale and clinical guideline recommendations for psychosocial screening in childhood diabetes
  • Explain the importance of family interactions and dynamics in diabetes management
  • Assess the different behavioural and psychological interventions for optimising diabetes management in children and adolescents

Centro de Experiencia

,

El Centro de Experiencia Jardiance▼® (Empagliflozina)* proporciona información sobre el uso de Jardiance.

Jardiance está indicado como medicamento adicional en el tratamiento de la diabetes mellitus tipo 2 en pacientes adultos cuando en combinación con otros medicamentos hipoglucemiantes, junto con la dieta y el ejercicio, no proporcionen un control glucémico adecuado. También está indicado como monoterapia en pacientes adultos en los que el uso de metformina se considere inapropiado debido a una intolerancia.

Los usuarios encontraran cuatro videos de expertos analizando el uso de inhibidores de SGLT2 centrándose en:

  • El paciente adecuado
  • Seguridad
  • Posición recomendada en el escalón terapéutico
  • Mecanismo de acción

*Este contenido es de tipo promocional, esponsorizado por Boehringer Ingelheim y Lilly.

†▼Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas a este medicamento

Obesity Learning Hub

,Obesity Learning Hub

The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.

Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.

Obesity CME series

,Obesity series

This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.

Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.

Module 2 – Considerations for Individualising Pharmacotherapy
Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care.

Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.

Upon successful completion of these modules, participants will receive a combined total of five European CME credits (ECMECs).

Latest News

Blog

Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.

Medical Videos

Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Diabetic Macular Edema
Diabetic Macular Edema
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
The Cause of Obesity
The Cause of Obesity
Peter Attia: What if we're wrong about diabetes?
Peter Attia: What if we're wrong about diabetes?

Recent Drug Updates

Medical Journal Abstracts on Diabetes and Endocrinology

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

Tue 18 Aug 2015 -  Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

IMPORTANCE: Weight loss of 5% to 10% can improve type 2 diabetes and related comorbidities. Few safe, effective weight-management drugs are currently available. OBJECTIVE: To investigate efficacy ...

Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.

Thu 13 Aug 2015 -  Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.

Background: Androgen deprivation therapy (ADT) is associated with increased cardiovascular morbidity. Objective: To determine whether cardiovascular morbidity differs following initiation of ...

Clinical Guidelines

Management of osteoporosis and the prevention of fragility fractures

Mar 2015

This guideline provides recommendations based on current evidence for best practice in the..

... management of osteoporosis and prevention of fractures. It addresses risk factors for fracture, commonly-used tools for assessment of fracture risk, approaches to targeting therapy, pharmacological, and non-pharmacological treatments to reduce fracture risk, treatment of painful vertebral fractures and systems of care. The assessment and prevention of falls is excluded as it was covered by a national resource published by NHS Quality Improvement Scotland in 2010, which aimed to prevent fractures in older people by raising the profile of falls,1and also a clinical guideline published by the National Institute for Health and Care Excellence (NICE) in 2013.2 The guideline also excludes issues surrounding the surgical management of fractures and postoperative care of patients with fractures.

This guideline will be of interest to rheumatologists, endocrinologists, general practitioners (GPs), physicians involved in care of the elderly, orthopaedic surgeons, gynaecologists, specialist nurses involved in the care of patients with osteoporosis and pharmacists.

Guidelines on Male Hypogonadism

Mar 2015

Androgens play a crucial role in the development and maintenance of male reproductive and sexual..

... functions. Low levels of circulating androgens can cause disturbances in male sexual development, resulting in congenital abnormalities of the male reproductive tract. Later in life, this may cause reduced fertility, sexual dysfunction, decreased muscle formation and bone mineralisation, disturbances of fat metabolism, and cognitive dysfunction. Testosterone levels decrease as a process of ageing: signs and symptoms caused by this decline can be considered a normal part of ageing. However, low testosterone levels are also associated with several chronic diseases, and symptomatic patients may benefit from testosterone treatment. This document presents the European Association of Urology (EAU) guidelines on diagnosis and treatment of male hypogonadism. This guideline aims to provide practical recommendations on how to deal with primary low testosterone and ageing-related decline in testosterone in male patients, as well as the treatment of testosterone disruption and deficiencies caused by other illnesses.

Online CME

Considerations for Individualising Pharmacotherapy

Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care. EACCME accredited.

Understanding Obesity

Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....

Individual Patient Management in Type 1 Childhood Diabetes

In this EACCME-accredited online CME activity healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes.

Clinical Trials

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function (LIRABONE)

Sat 01 Aug 2015

The purpose of this study is to test whether liraglutide, a drug approved and widely used in the treatment of type 2 diabetes, has an effect on bone mass ...

Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI

Wed 01 Jul 2015

To determine the difference in clinical pregnancy rates with and without luteal progesterone support in a young reproductive aged population having undergone ovulation induction ...

Back to top